Ownership history in JOHNSON & JOHNSON · 10 quarters on record
This page tracks every 13F SEC filing in which JOHNSON & JOHNSON reported a position in Neumora Therapeutics, Inc. (NMRA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,849,445 | — | 0% | 0.60% | $3.3M | $1.79 |
| 2025 Q3 | UNCHANGED | 1,849,445 | — | 0% | 0.67% | $3.4M | $1.82 |
| 2025 Q2 | UNCHANGED | 1,849,445 | — | 0% | 0.42% | $1.4M | $0.73 |
| 2025 Q1 | UNCHANGED | 1,849,445 | — | 0% | 0.54% | $1.8M | $1.00 |
As of 2025 Q4 — sorted by position size